Literature DB >> 2919200

Intralesional corticosteroid therapy for infantile hemangiomas.

G M Sloan1, J F Reinisch, L S Nichter, W L Saber, K Lew, D T Morwood.   

Abstract

Intralesional corticosteroid injections were performed in 31 hemangiomas in 30 infants aged 1 to 10 months at first injection. One to five injections were given, spaced 6 weeks apart. Lesions were located throughout the head and neck region, except one that was on the buttock. A mixture of betamethasone acetate and triamcinolone acetonide was used. Four lesions (13 percent) virtually disappeared, ten (32 percent) showed greater than 50 percent reduction in volume, ten (32 percent) showed definite but less than 50 percent reduction in volume, and seven (23 percent) showed little or no decrease in size. None showed further growth. All injections were performed without anesthesia, and there were not significant complications. We conclude that intralesional corticosteroid injections are safe and effective in properly selected infants with hemangiomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919200     DOI: 10.1097/00006534-198903000-00009

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  9 in total

1.  How to Manage Disfiguring Scars in Involuted Infantile Hemangioma.

Authors:  Shunsuke Yuzuriha; Fumio Nagai; Masahiko Noguchi
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-06-06       Impact factor: 4.730

2.  Imaging and percutaneous treatment of vascular anomalies.

Authors:  Sandeep Vaidya; Daniel Cooke; Matthew Kogut; Peter G Stratil; Mark A Bittles; Manrita Sidhu
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

3.  Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.

Authors:  R R Ricketts; R M Hatley; B J Corden; H Sabio; C G Howell
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

4.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Authors:  K Takahashi; J B Mulliken; H P Kozakewich; R A Rogers; J Folkman; R A Ezekowitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 5.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.

Authors:  T Muir; M Kirsten; P Fourie; N Dippenaar; G O Ionescu
Journal:  Pediatr Surg Int       Date:  2004-01-22       Impact factor: 1.827

6.  Anesthetic and airway management of a child with a large upper-lip hemangioma.

Authors:  Sukhminderjit Singh Bajwa; Aparajita Panda; Sukhwinder Kaur Bajwa; Amarjit Singh; S S Parmar; Kanwalpreet Singh
Journal:  Saudi J Anaesth       Date:  2011-01

7.  Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model.

Authors:  Dan Xu; Teresa M O; Archil Shartava; Taylor C Fowles; Jianchang Yang; Louis M Fink; David C Ward; Martin C Mihm; Milton Waner; Yupo Ma
Journal:  J Hematol Oncol       Date:  2011-12-22       Impact factor: 17.388

8.  The synergistic effect of bleomycin, triamcinolone and epinephrine in treatment of hemangioma and arteriovenous malformations.

Authors:  Hamid Masiha; Heydar Ali Nikpour; Mohammad Esmaeil Hasani; Abolhasan Emami; Mehryar Jafari; Ali Manafi
Journal:  World J Plast Surg       Date:  2012-07

9.  Treatment of hemangiomas in children using a Nd:YAG laser in conjunction with ice cooling of the epidermis: techniques and results.

Authors:  Ioannis Vlachakis; Stefanos Gardikis; Eleni Michailoudi; Georgios Charissis
Journal:  BMC Pediatr       Date:  2003-04-12       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.